Thirty participants were interviewed: 22 females (73%), aged 31-70 years (28, 94%), comprising patients (n = 8), caregivers (n = 2), medical oncologists (n = 4 ...
Please provide your email address to receive an email when new articles are posted on . Few adverse events were reported in OPAT containing cefazolin and ceftriaxone. Only 2.7 clinically significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results